The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound

Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

[search][options]

Editor

Personal info

View

About

Terms

Javascript disabled

Please enable Javascript support in your browser to use this application.

Instructions on how to enable JavaScript on different browsers can be found here: http://www.google.com/support/bin/answer.py?answer=23852.

Jan Wehkamp

Department of Microbiology and Immunology

University of California

Davis

CA 95616

USA

[email]@ucdavis.edu

Name/email consistency: high

[Claim this account]

Affiliations

Department of Microbiology and Immunology, University of California, Davis, CA 95616, USA. 2005
University of California-Davis School of Medicine, Department of Microbiology and Immunology, 1 Shield Avenue, Tupper Hall 3146, USA. 2005
Department of Internal Medicine I, Robert Bosch Hospital, Stuttgart, Germany. 2004

References

Defensin deficiency, intestinal microbes, and the clinical phenotypes of Crohn's disease. Wehkamp, J., Schmid, M., Fellermann, K., Stange, E.F. J. Leukoc. Biol. (2005) [Pubmed]
NOD2 mutation and mice: no Crohn's disease but many lessons to learn. Wehkamp, J., Stange, E.F. Trends. Mol. Med (2005) [Pubmed]
Mechanisms of disease: defensins in gastrointestinal diseases. Wehkamp, J., Fellermann, K., Herrlinger, K.R., Bevins, C.L., Stange, E.F. Nature Clinical Practice. Gastroenterology & Hepatology (2005) [Pubmed]
NF-kappaB- and AP-1-mediated induction of human beta defensin-2 in intestinal epithelial cells by Escherichia coli Nissle 1917: a novel effect of a probiotic bacterium. Wehkamp, J., Harder, J., Wehkamp, K., Wehkamp-von Meissner, B., Schlee, M., Enders, C., Sonnenborn, U., Nuding, S., Bengmark, S., Fellermann, K., Schröder, J.M., Stange, E.F. Infect. Immun. (2004) [Pubmed]